AEPCX
Price
$54.76
Change
-$0.05 (-0.09%)
Updated
Nov 14 closing price
AIMOX
Price
$17.52
Change
+$0.02 (+0.11%)
Updated
Nov 14 closing price
Ad is loading...

AEPCX vs AIMOX

Header iconAEPCX vs AIMOX Comparison
Open Charts AEPCX vs AIMOXBanner chart's image
American Funds Europacific Growth C
Price$54.76
Change-$0.05 (-0.09%)
VolumeN/A
CapitalizationN/A
AQR International Momentum Style I
Price$17.52
Change+$0.02 (+0.11%)
VolumeN/A
CapitalizationN/A
AEPCX vs AIMOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. AIMOX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AIMOX is a Buy.

FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 131B vs. AIMOX (190M). AIMOX pays higher dividends than AEPCX: AIMOX (5.67) vs AEPCX (0.81). AEPCX was incepted earlier than AIMOX: AEPCX (24 years) vs AIMOX (15 years). AIMOX is a more actively managed with annual turnover of: 72.00 vs. AEPCX (34.00). AEPCX has a lower initial minimum investment than AIMOX: AEPCX (250) vs AIMOX (5000000). AIMOX annual gain was more profitable for investors over the last year : 11.11 vs. AEPCX (8.37). AIMOX return over 5 years is better than : 29.44 vs. AEPCX (5.27).
AEPCXAIMOXAEPCX / AIMOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years15 years-
Gain YTD4.10010.75938%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets131B190M68,947%
Annual Yield % from dividends0.815.6714%
Returns for 1 year8.3711.1175%
Returns for 3 years-18.72-4.33433%
Returns for 5 years5.2729.4418%
Returns for 10 years18.9752.0936%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDT50.77-0.24
-0.47%
IDT Corp
MTR5.92-0.03
-0.50%
Mesa Royalty Trust
EC7.36-0.10
-1.34%
Ecopetrol SA
ENTA10.44-0.22
-2.06%
Enanta Pharmaceuticals
ACLS79.72-3.01
-3.64%
Axcelis Technologies